considerationsLicence data EU, USPregnancy cat. D (Au)Legal status S4 avapro substitute POM (UK), ?-only (U.S.)Routes OralIrbesartan (INN) (pronounced /?rb??s?rt?n/) is an angiotensin II receptor antagonists, irbesartan is indicated for the treatment of hypertension. Irbesartan was developed avapro substitute Sanofi.

similar trade names Aprovel, Karvea, and avapro substitute [hide]1 Clinical use1.1 Indications1.2 Combination with diureticIrbesartan is also available in a combination formulation with a low dose thiazide diuretic, invariably hydrochlorothiazide, avapro substitute achieve an additive antihypertensive effect. Irbesartan/hydrochlorothiazide avapro substitute preparations are marketed under similar trade names to irbesartan preparations, including CoAprovel, Karvezide, Avalide and Avapro HCT.[edit] References^ Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, Ritz E, Atkins RC, avapro substitute R, Raz avapro substitute Collaborative Study Group. (2001). "Renoprotective effect of the angiotensin-receptor antagonist irbesartan avapro substitute patients with nephropathy due to type 2 diabetes.". N Engl J Med 345 (12): 851-60. PMID 11565517.^ Rossi S, editor. avapro substitute Medicines Handbook 2006. Adelaide: Australian Medicines Handbook 2006. Adelaide: Australian Medicines Handbook; 2006. ISBN 0-9757919-2-3 IrbesartanFrom Wikipedia, the free encyclopedia(Redirected from.

faecal 65%Therapeutic considerationsLicence data EU, USPregnancy cat. D (Au)Legal status S4 (Au), POM (UK), ?-only.